After the failed Albertsons merger, Kroger launched a $7.5B share repurchase and is quietly building a high-margin retail media business through Kroger Precision Marketing. Here's whether KR belongs in your 2026 US consumer portfolio.
Philip Morris International's EPS surged 60% in 2025, driven by IQOS Heat-not-burn growth and ZYN nicotine pouches from the Swedish Match acquisition. Here's whether PM's smoke-free transformation makes it a dividend growth stock worth holding in 2026.
Kraft Heinz (KHC) stock analysis for 2026. We assess the Berkshire Hathaway stake reduction, the $5.76 billion net loss from goodwill impairments, CEO Cahillane's $600M brand reinvestment plan, organic sales decline, GLP-1 headwinds on processed food, and whether the 6.8% dividend is safe.
Hershey (HSY) stock analysis for 2026. We examine the West Africa cocoa supply collapse, SkinnyPop and Dot's Pretzels salty snack diversification, Q1 2026 adjusted EPS of $2.35 beating $2.04 consensus, GLP-1 drug effects on candy sales, and the Mondelez rejected acquisition backstory.
Biogen (BIIB) stock analysis for 2026. We evaluate Leqembi's actual prescription trajectory, the Spinraza revenue decline, Skyclarys rare disease growth, diranersen Phase 2 tau data, and whether the 55% bounce from $121 to $188 is justified.
Devon Energy completed its Coterra Energy merger on May 7, 2026, unlocking $1B in synergies, an $8B buyback, and a 30% dividend hike. Here's how US retail investors should size DVN in a 401k or taxable account in 2026.